Synthesis and anti-cancer activity of naphthalimide–organylselanyl conjugates

• Rajkumar Ravi and
• Selvakumar Karuthapandi

Beilstein J. Org. Chem. 2026, 22, 416–435, doi:10.3762/bjoc.22.29

• structurally characterised by single-crystal X-ray diffraction analysis. The anticancer potential of the NAP-SePh and NAP-Se(n-Oct) was evaluated using an in vitro cell viability assay with MDA-MB-231 triple-negative breast cancer (TNBC) cells. The IC₅₀ values for compounds NAP-SePh and NAP-Se(n-Oct) were

• epidermal growth factor receptor (EGFR) in which erlotinib, a well-known anticancer drug, binds. Keywords: cell line study; density functional theory; MDA-MB-231; molecular docking; organoselanyl conjugates; Introduction Cancer remains one of the most common and life-threatening diseases globally, posing

• methylseleninic acid (1) has emerged as a promising drug candidate for the treatment of triple-negative breast cancer (TNBC) [27]. In addition, the classical organoselenium compound diphenyl diselenide (2) has shown significant anticancer activity against the MDA-MB-231 breast cancer cell line [28]. Very recently

Synthesis and cytotoxicity studies of novel N-arylbenzo[h]quinazolin-2-amines

• Battini Veeraiah,
• Kishore Ramineni,
• Dabbugoddu Brahmaiah,
• Nangunoori Sampath Kumar,
• Hélène Solhi,
• Rémy Le Guevel,
• Chada Raji Reddy,
• Frédéric Justaud and
• René Grée

Beilstein J. Org. Chem. 2024, 20, 2592–2598, doi:10.3762/bjoc.20.218

• Next, we performed a cytotoxicity screening of the nineteen molecules 4a–s, at 25 μM, investigating seven representative cancer cell lines: hepatocellular carcinoma HuH-7, colorectal adenocarcinoma CaCo-2, breast carcinoma MDA-MB-231 and MDA-MB-468, colorectal carcinoma HCT-116, prostate carcinoma PC3

• , 272.1181 (0 ppm); mp: 195–197 °C. Protocole ImPACell for cytotoxicity studies Cell culture. Skin normal fibroblastic cells are purchased from Lonza (Basel, Switzerland), HuH-7, Caco-2, MDA-MB-231, HCT-116, PC3, MCF7 and NCI-H727 cancer cell lines were obtained from ATCC (American Type Culture Collection

• ). Cells are grown at 37 °C, 5% CO2 in ATCC recommended media: DMEM for HuH-7, MDA-MB-231, MDA-MB-468 and fibroblast, EMEM for MCF7 and CaCo-2, McCoy’s for HCT-116 and RPMI for PC3 and NCI-H727. All culture media are supplemented by 10% of FBS, 1% of penicillin-streptomycin and 2 mM glutamine. Cytotoxic

The Groebke–Blackburn–Bienaymé reaction in its maturity: innovation and improvements since its 21st birthday (2019–2023)

• Cristina Martini,
• Muhammad Idham Darussalam Mardjan and
• Andrea Basso

Beilstein J. Org. Chem. 2024, 20, 1839–1879, doi:10.3762/bjoc.20.162

Synthesis of ether lipids: natural compounds and analogues

• Marco Antônio G. B. Gomes,
• Alicia Bauduin,
• Chloé Le Roux,
• Romain Fouinneteau,
• Wilfried Berthe,
• Mathieu Berchel,
• Hélène Couthon and
• Paul-Alain Jaffrès

Beilstein J. Org. Chem. 2023, 19, 1299–1369, doi:10.3762/bjoc.19.96

A novel spirocyclic scaffold accessed via tandem Claisen rearrangement/intramolecular oxa-Michael addition

• Anastasia Vepreva,
• Alexander Yanovich,
• Dmitry Dar’in,
• Grigory Kantin,
• Alexander Bunev and
• Mikhail Krasavin

Beilstein J. Org. Chem. 2022, 18, 1649–1655, doi:10.3762/bjoc.18.177

• completely unreactive towards the Claisen rearrangement step, even at 150 °C in 1,2-dichlorobenzene. Raising the temperature to 200 °C led to starting material deterioration and was not productive either. Spirocyclic products 7a–l were tested for their ability to influence the survival of MDA-MB-231 (breast

Synthesis of new bile acid-fused tetrazoles using the Schmidt reaction

• Dušan Đ. Škorić,
• Olivera R. Klisurić,
• Dimitar S. Jakimov,
• Marija N. Sakač and
• János J. Csanádi

Beilstein J. Org. Chem. 2021, 17, 2611–2620, doi:10.3762/bjoc.17.174

• six human tumor cell lines (MCF-7 estrogen receptor positive breast adenocarcinoma, MDA-MB-231 estrogen receptor negative breast adenocarcinoma, PC-3 prostate cancer, HeLa cervix carcinoma, HT-29 colon adenocarcinoma, and A549 adenocarcinomic human alveolar basal epithelial cells). Standard MTT assay

• [52] was used with commercial nonselective antitumor agent doxorubicin (DOX) as control [53]. The results of antiproliferative in vitro analysis of all tested compounds are shown in Table 4. Among all tested compounds, ketone 3 showed the lowest IC50 value (1.06 μM) towards MDA-MB-231 cells, with

• linear dose dependence of cytotoxicity through the tested concentration range (Figure 4A). Compound 3 also showed strong activity on the HeLa cell line. Introduction of tetrazole ring instead of ketone diminished activity toward the MDA-MB-231 cell line in compound 13 (IC50 > 100 μM). The same trend with

Extension of the 5-alkynyluridine side chain via C–C-bond formation in modified organometallic nucleosides using the Nicholas reaction

• Renata Kaczmarek,
• Dariusz Korczyński,
• James R. Green and
• Roman Dembinski

Beilstein J. Org. Chem. 2020, 16, 1–8, doi:10.3762/bjoc.16.1

• hexacarbonyls with 2'-deoxyuridines revealed pronounced in vitro activity against MCF-7 and MDA-MB-231 human breast cancer cells [32][33]. A recent investigation of hexacarbonyl dicobalt adducts of nucleosides containing derivatives of propargyl alcohol demonstrated their antiproliferative activities for the

Synthesis of a tubugi-1-toxin conjugate by a modulizable disulfide linker system with a neuropeptide Y analogue showing selectivity for hY1R-overexpressing tumor cells

• Rainer Kufka,
• Robert Rennert,
• Goran N. Kaluđerović,
• Lutz Weber,
• Wolfgang Richter and
• Ludger A. Wessjohann

Beilstein J. Org. Chem. 2019, 15, 96–105, doi:10.3762/bjoc.15.11

• (Ewing`s sarcoma), MDA-MB-468, MDA-MB-231 (both breast cancer) and 184B5 (normal breast; chemically transformed) were investigated. As hoped, the toxicity of tubugi-1 was masked, with IC50 values decreased by ca. 1,000-fold compared to the free toxin. Due to intracellular linker cleavage, the cytotoxic

• -qPCR (Figure 2C). Both the cytotoxic activity and the hY1R expression level rank in the order SK-N-MC > MDA-MB-468 > MDA-MB-231 > 184B5, what proofs the hY1R-specific and -selective nature of the mode of antitumor action of the designed PDC 8. Importantly, the activity of 8 against the selected normal

• breast cell line 184B5 is in the same order of magnitude as for the hY1R-deficient tumor cell line (MDA-MB-231), both tested at even higher concentration of the PDC than for the Y1 cell lines. This points out good selectivity not only between tumor cell lines with the different hY1R expression levels but

Microwave-assisted synthesis of biologically relevant steroidal 17-exo-pyrazol-5'-ones from a norpregnene precursor by a side-chain elongation/heterocyclization sequence

• Gergő Mótyán,
• László Mérai,
• Márton Attila Kiss,
• Zsuzsanna Schelz,
• Izabella Sinka,
• István Zupkó and
• Éva Frank

Beilstein J. Org. Chem. 2018, 14, 2589–2596, doi:10.3762/bjoc.14.236

• '-ones and their deacetylated analogs were screened on three human adherent breast cancer cell lines (MCF7, T47D and MDA-MB-231): the microculture tetrazolium assay revealed that some of the presented derivatives exerted cell growth inhibitory effects on some of these cell lines comparable to those of

• also determined on three human breast malignant cell lines (MCF7, T47D, and MDA-MB-231) by means of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay [20]. Furthermore, the most promising molecules were additionally tested on mouse fibroblasts (NIH-3T3) in order to obtain

• antiproliferative effects were determined by means of the MTT assay [20] on a panel of adherent breast cancer cell lines (MCF7, T47D and MDA-MB-231) after treatment for 72 h (Table 2). All compounds were initially screened at 10 and 30 μM concentrations and for those compounds that elicited growth inhibition of at

On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site

• Eirinaios I. Vrettos,
• Gábor Mező and
• Andreas G. Tzakos

Beilstein J. Org. Chem. 2018, 14, 930–954, doi:10.3762/bjoc.14.80

• and MDA-MB-231 hormone- independent [125]. They proved that the specific analogs retained the high binding affinity of the D-Lys6-LHRH carrier to the relevant receptors. Both conjugates displayed IC50 values in the low nanomolar concentration range for MCF-7 (13.7 ± 1.09 nM for AN-152 and 6.08 ± 0.5

• nM for AN-207) and MDA-MB-231 (5.60 ± 1.24 nM for AN-152 and 1.89 ± 0.4 nM for AN-207) cells. AN-152 was tested regarding the inhibition of tumor growth of subcutaneously (sc) implanted androgen-dependent LNCaP and MDA-PCa-2b and androgen-independent C4-2 prostate cancers, xenografted into nude mice

Stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing

• Françoise Debart,
• Christelle Dupouy and
• Jean-Jacques Vasseur

Beilstein J. Org. Chem. 2018, 14, 436–469, doi:10.3762/bjoc.14.32

Glyco-gold nanoparticles: synthesis and applications

• Federica Compostella,
• Olimpia Pitirollo,
• Alessandro Silvestri and
• Laura Polito

Beilstein J. Org. Chem. 2017, 13, 1008–1021, doi:10.3762/bjoc.13.100

• immunosorbent assay (ELISA), the selectivity and sensitivity of the binding were demonstrated to be dependent on the sugar nature and on the NP morphology. The cellular uptake experiments on HeLa, HepG2 and MDA-MB-231 cells showed in fact an higher clathrin-mediated internalization for rod-shaped AuNPs in

Synthesis and evaluation of anti-oxidant and cytotoxic activities of novel 10-undecenoic acid methyl ester based lipoconjugates of phenolic acids

• Naganna Narra,
• Shiva Shanker Kaki,
• Rachapudi Badari Narayana Prasad,
• Sunil Misra,
• Koude Dhevendar,
• Venkateshwarlu Kontham and
• Padmaja V. Korlipara

Beilstein J. Org. Chem. 2017, 13, 26–32, doi:10.3762/bjoc.13.4

• , compound 3c was found to exhibit best anticancer activity against MCF7, DU145 and MDA-MB-231 cell lines with IC50 values of 10.55, 13.0 and 12.0 µM, respectively. It was found that the anticancer activity against some cell lines was much better compared to our previous reports on phenolic lipids [19

• different cancer cell lines viz., MDA-MB-231, breast cancer (ATCC® HTB-26™); SKOV3, ovarian cancer (ATCC® HTB-77™); MCF7, breast cancer (ATCC® HTB-22™); DU 145, prostate cancer (ATCC® HTB-81™); HepG2, liver hepatocellular carcinoma (ATCC® HB-8065™) were obtained from the ATCC (Bethesda, MD, USA) and

Aspergiloid I, an unprecedented spirolactone norditerpenoid from the plant-derived endophytic fungus Aspergillus sp. YXf3

• Zhi Kai Guo,
• Rong Wang,
• Wei Huang,
• Xiao Nian Li,
• Rong Jiang,
• Ren Xiang Tan and
• Hui Ming Ge

Beilstein J. Org. Chem. 2014, 10, 2677–2682, doi:10.3762/bjoc.10.282

• myeloid leukemia, SH-SY5Y neuroblastoma, SGC-7901 gastric adenocarcinoma, HepG2, SMMC-7721 hepatocellular carcinoma, A549 lung cancer, MCF-7, MDA-MB-231 breast cancer, HCT116, SW480 colon cancer, HT29 colorectal cancer. However, no significant activity was detected (IC50 > 50 μM). It also displayed no

• desposit@ccdc.cam.ac.uk. Biological assays Cytotoxic activity against 11 human cancer cell lines, K562 myeloid leukemia, SH-SY5Y beuroblastoma, SGC-7901 gastric adenocarcinoma, HepG2, SMMC-7721 hepatocellular carcinoma, A549 lung cancer, MCF-7, MDA-MB-231 breast cancer, HCT116, SW480 colon cancer, HT29

Efficient syntheses of 25,26-dihydrodictyostatin and 25,26-dihydro-6-epi-dictyostatin, two potent new microtubule-stabilizing agents

• María Jiménez,
• Wei Zhu,
• Andreas Vogt,
• Billy W. Day and
• Dennis P. Curran

Beilstein J. Org. Chem. 2011, 7, 1372–1378, doi:10.3762/bjoc.7.161

• comparable to (−)-dictyostatin and discodermolide. Each compound also inhibited the growth of cell lines resistant to paclitaxel and epothilone B at low nanomolar concentrations, synergized with paclitaxel in MDA-MB-231 human breast cancer cells, and had anti-angiogenic activity in transgenic zebra fish